Your browser doesn't support javascript.
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr, Marcel A; Divangahi, Maziar; Schurr, Erwin.
  • Behr MA; Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Divangahi M; McGill International TB Centre, Montreal, Quebec, Canada.
  • Schurr E; Infectious Diseases and Immunity in Global Health, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.
J Infect Dis ; 223(2): 189-191, 2021 02 03.
Article in English | MEDLINE | ID: covidwho-1101844
ABSTRACT
Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a "new" vaccine introduced in 1921, namely bacille Calmette-Guérin.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: BCG Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: BCG Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Animals / Humans Language: English Journal: J Infect Dis Year: 2021 Document Type: Article Affiliation country: Infdis